- Home
- SHMD vs NVCT Comparison
SHMD vs NVCT Comparison
Compare SHMD & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHMD
- NVCT
- Stock Information
- Founded
- SHMD 1864
- NVCT 2020
- Country
- SHMD Germany
- NVCT United States
- Employees
- SHMD N/A
- NVCT N/A
- Industry
- SHMD
- NVCT Medicinal Chemicals and Botanical Products
- Sector
- SHMD
- NVCT Health Care
- Exchange
- SHMD Nasdaq
- NVCT Nasdaq
- Market Cap
- SHMD 144.7M
- NVCT 119.4M
- IPO Year
- SHMD N/A
- NVCT 2022
- Fundamental
- Price
- SHMD $2.54
- NVCT $4.90
- Analyst Decision
- SHMD
- NVCT Strong Buy
- Analyst Count
- SHMD 0
- NVCT 1
- Target Price
- SHMD N/A
- NVCT $21.00
- AVG Volume (30 Days)
- SHMD 31.5K
- NVCT 303.6K
- Earning Date
- SHMD 12-03-2024
- NVCT 11-05-2024
- Dividend Yield
- SHMD N/A
- NVCT N/A
- EPS Growth
- SHMD 1309.32
- NVCT N/A
- EPS
- SHMD 1.07
- NVCT N/A
- Revenue
- SHMD $99,752,404.00
- NVCT N/A
- Revenue This Year
- SHMD N/A
- NVCT N/A
- Revenue Next Year
- SHMD N/A
- NVCT N/A
- P/E Ratio
- SHMD $2.23
- NVCT N/A
- Revenue Growth
- SHMD N/A
- NVCT N/A
- 52 Week Low
- SHMD $2.26
- NVCT $4.69
- 52 Week High
- SHMD $6.13
- NVCT $12.10
- Technical
- Relative Strength Index (RSI)
- SHMD N/A
- NVCT 35.71
- Support Level
- SHMD N/A
- NVCT $4.75
- Resistance Level
- SHMD N/A
- NVCT $5.49
- Average True Range (ATR)
- SHMD 0.00
- NVCT 1.14
- MACD
- SHMD 0.00
- NVCT -0.52
- Stochastic Oscillator
- SHMD 0.00
- NVCT 3.02
About SHMD SCHMID Group N.V. Class A Ordinary Shares
Schmid Group NV is a global supplier of equipment, software and services for various industries such as printed circuit board (PCB), substrate manufacturing, photovoltaics, and glass and energy storage with a focus on the highest end of this market in terms of technology and performance. It focuses on a modular product portfolio of machinery to use in the manufacturing of high-end PCB equipment and semiconductor packaging devices which includes common flexible circuit fabrication techniques such as subtractive, semi-additive processes (SAP) and modified semi-additive processes (mSAP).
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.